David Koehler

Dr. David Koehler joined OICR’s Commercialization group in 2007.
His responsibilities include managing the Prospects and Compass Rose Funds, managing OICR’s investments in start-up companies, facilitating the identification and protection of OICR’s intellectual property (IP), negotiating and drafting contracts, systems administration for the contracts and IP database, and tracking key performance indicators of OICR’s commercialization activity.
From 2005 to 2006, Dr. Koehler held the position of Pharmaceutical Analyst at Drug Royalty Corporation and served a similar role with SHI Consulting in 2007.
Prior to that, he was a researcher at the Hospital for Sick Children and recipient of the prestigious Medical Research Council and Canadian Cystic Fibrosis Foundation fellowships.
Dr. Koehler holds a PhD in Biological Sciences from Stanford University, and a BSc (Honours) in Biology from York University.